$15.730
-0.967 (-6.15%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による AKTS の予測・予想
Alphio's AKTS stock price prediction model matches the current Aktis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.83 (+0.65%). The 1-week path is $15.92 (+1.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Aktis Oncology Inc 株は買うべき？
Aktis Oncology (AKTS) appears to be a good buy right now, especially given its current price of $15.73, which is significantly below the analyst price targets of $40 and $35. The company has a strong gross margin of 100%, indicating effective cost management in its operations. However, it is important to note the risk of its net income, which has been negative, with a reported net income of -24,144,000 USD in Q2 2026. This financial performance, combined with the potential upside indicated by the analyst ratings, supports a buy recommendation.
AKTS の株価は Friday に $15.73 で引け、その前に下落 -6.15%
Aktis Oncology Inc (AKTS) last closed at $15.73, losing -6.15%. These facts feed the 1-day and 1-week AKTS price prediction above.
アナリストのコンセンサス
Aktis Oncology Inc（AKTS）：買い 3、中立 0、売り 0。見通し：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
予想の要因
Aktis Oncology Inc（AKTS）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが AKTS に最も近い銘柄を、類似度順に表示します。
AKTS の季節性分析
Historically the probability of a positive October return for AKTS is 0.00%. August offers the highest probability of a positive month at 46.51%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。